Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Rates of chronic medication prescriptions a. and prescriptions filled at community pharmacies over time

From: Utilization of oral antidiabetic medications in Taiwan following strategies to promote access to medicines for chronic diseases in community pharmacies

   2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Overall           
  Rate of chronic medication prescriptions for diabetes (%)d. 3.54% 5.65% 9.40% 12.84% 15.77% 19.94% 23.13% 25.29% 26.55% 26.24%
  Share of prescriptions filled at community pharmacies (%)e. 3.67% 5.52% 8.38% 10.40% 14.20% 16.68% 19.37% 23.46% 28.14% 31.30%
  Share of reimbursed expenditures accounted by community pharmacies (%)f. 3.36% 4.97% 7.11% 9.30% 13.71% 16.23% 19.51% 24.48% 29.22% 32.35%
Subgroups by class           
  Share of prescriptions filled at community pharmacies (%) e.       
  Biguanides 3.43% 5.31% 8.39% 10.44% 14.12% 16.73% 19.52% 23.32% 28.22% 31.66%
  Sulfonylureas 4.01% 6.22% 9.59% 11.80% 15.58% 17.96% 20.17% 24.06% 28.42% 31.29%
  Alpha-glucosidase inhibitors 0.94% 1.98% 3.17% 6.14% 10.27% 13.38% 17.06% 22.02% 27.48% 30.95%
  Thiazolidinediones 1.21% 2.93% 4.66% 6.81% 11.23% 13.67% 18.18% 23.91% 29.23% 32.00%
  Dipeptidyl peptidase-4 inhibitors N/A c. N/A N/A N/A N/A N/A N/A N/A 24.89% 30.32%
  Othersb. 1.30% 1.51% 3.40% 5.30% 8.87% 11.99% 15.25% 20.12% 25.42% 28.59%
  Share of reimbursed expenditures accounted by community pharmacies (%) f.     
  Biguanides 3.23% 5.07% 7.71% 9.98% 13.91% 16.92% 20.47% 24.77% 29.51% 32.91%
  Sulfonylureas 3.85% 6.24% 9.49% 12.06% 16.61% 18.85% 21.13% 25.26% 29.73% 32.80%
  Alpha-glucosidase inhibitors 0.75% 1.67% 2.78% 5.46% 9.47% 12.72% 16.47% 21.77% 27.63% 31.36%
  Thiazolidinediones 1.12% 2.93% 4.29% 6.56% 11.18% 13.76% 18.62% 24.88% 30.28% 33.23%
  Dipeptidyl peptidase-4 inhibitors N/A N/A N/A N/A N/A N/A N/A N/A 25.81% 31.13%
  Othersb. 1.28% 1.38% 2.99% 5.11% 8.71% 11.88% 15.38% 20.97% 26.41% 29.80%
  1. a. Chronic medication prescriptions allow prescriptions to be refilled once a month for two times for a total of three months’ supply of medications, without repeat visits to a doctor’s office.
  2. b. Others: guar gum, repaglinide, nateglinide, exenatide, liraglutide, mitiglinide.
  3. c. N/A = not applicable.
  4. d. Rate of chronic medication prescriptions for diabetes = annual number of chronic medication prescriptions for diabetes/annual number of diabetic outpatient visits.
  5. e. Share of prescriptions filled at community pharmacies = aggregated annual volume (DDDs) of prescription filled at community pharmacies/aggregated annual volume (DDDs) of prescription filled at both hospital and community pharmacies.
  6. f. Share of reimbursed expenditures accounted by community pharmacies = aggregated annual reimbursed expenditures accounted by community pharmacies/aggregated annual reimbursed expenditures accounted by both hospital and community pharmacies.